Profiel
Ming Lun Tse currently works at Tian Ge Interactive Holdings Ltd., as Independent Non-Executive Director from 2022, Adlai Nortye Ltd., as Independent Non-Executive Director from 2021, and Association of Chartered Certified Accountants (Hong Kong), as Member from 2005.
Mr. Tse also formerly worked at Next Horizon Co. Ltd., as Senior Manager-Corporate Planning & Development from 2007 to 2009.
Mr. Tse received his undergraduate degree in 2002 from The University of Hong Kong.
Actieve functies van Ming Lun Tse
| Bedrijven | Functie | Begin |
|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Bestuurslid | 13-07-2021 |
| TIAN GE INTERACTIVE HOLDINGS LIMITED | Directeur/Bestuurslid | 18-08-2022 |
Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal | 01-12-2005 |
Eerdere bekende functies van Ming Lun Tse
| Bedrijven | Functie | Einde |
|---|---|---|
Next Horizon Co. Ltd.
Next Horizon Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business process outsourcing services | Corporate Officer/Principal | 01-08-2009 |
Opleiding van Ming Lun Tse
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Chartered Certified Accountants (Hong Kong) | |
Tian Ge Interactive Holdings Ltd.
Tian Ge Interactive Holdings Ltd. Information Technology ServicesTechnology Services Operates live social video communities | Technology Services |
Next Horizon Co. Ltd.
Next Horizon Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business process outsourcing services | Commercial Services |
Adlai Nortye Ltd.
Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
















